Evidence map›Paper›PMID 36611121›Full record

ArticleOncogene2023

Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodeling.

Nicholas Nikesitch, Eliana Beraldi, Fan Zhang, Hans Adomat, Robert Bell, Kotaro Suzuki, Ladan Fazli, Sonia Hy Kung, Christopher Wells, Nicholas Pinette and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Nicholas NikesitchVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Eliana BeraldiVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Fan ZhangVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Hans AdomatVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Robert BellVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-2456-0972
Kotaro SuzukiVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Ladan FazliVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Sonia Hy KungVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Christopher WellsVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Nicholas PinetteVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Neetu SaxenaVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Yuzhuo WangVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-9749-8591
Martin GleaveVancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. m.gleave@ubc.ca.ORCID 0000-0003-4235-0167
University of British Columbia · CAUniversity of British Columbia Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The androgen receptor (AR) plays an important role in PCa metabolism, with androgen receptor pathway inhibition (ARPI) subjecting PCa cells to acute metabolic stress caused by reduced biosynthesis and energy production. Defining acute stress response mechanisms that alleviate ARPI stress and therefore mediate prostate cancer (PCa) treatment resistance will help improve therapeutic outcomes of patients treated with ARPI. We identified the up-regulation of chaperone-mediated autophagy (CMA) in response to acute ARPI stress, which persisted in castration-resistant PCa (CRPC); previously undefined in PCa. CMA is a selective protein degradation pathway and a key stress response mechanism up-regulated under several stress stimuli, including metabolic stress. Through selective protein degradation, CMA orchestrates the cellular stress response by regulating cellular pathways through selective proteome remodeling. Through broad-spectrum proteomic analysis, CMA coordinates metabolic reprogramming of PCa cells to sustain PCa growth and survival during ARPI; through the upregulation of mTORC1 signaling and pathways associated with PCa biosynthesis and energetics. This not only promoted PCa growth during ARPI, but also promoted the emergence of CRPC in-vivo. During CMA inhibition, PCa metabolism is compromised, leading to ATP depletion, resulting in a profound anti-proliferative effect on PCa cells, and is enhanced when combined with ARPI. Furthermore, CMA inhibition prevented in-vivo tumour formation, and also re-sensitized enzalutamide-resistant cell lines in-vitro. The profound anti-proliferative effect of CMA inhibition was attributed to cell cycle arrest mediated through p53 transcriptional repression of E2F target genes. In summary, CMA is an acute ARPI stress response mechanism, essential in alleviating ARPI induced metabolic stress, essential for ensuring PCa growth and survival. CMA plays a critical role in the development of ARPI resistance in PCa.

Indexed as

Chaperone-Mediated AutophagyProstatic Neoplasms, Castration-ResistantAndrogensAutophagyCell Line, TumorHumansMaleProteomeProteomicsReceptors, AndrogenAndrogensProteomeReceptors, Androgen

Identifiers

PMID36611121
OpenAlexW4313679928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.